Treatment options for nonalcoholic steatohepatitis - a safety evaluation.
about
Role of mitochondria and mitochondria targeted agents in non-alcoholic fatty liver disease.Editorial: treatments for non-alcoholic steatohepatitis - still a long way to go.Reduction of Liver Span and Parameters of Inflammation in Nonalcoholic Fatty Liver Disease Patients Treated with Lycosome Formulation of Phosphatidylcholine: A Preliminary Report.Apoptosis and non-alcoholic fatty liver diseases.
P2860
Treatment options for nonalcoholic steatohepatitis - a safety evaluation.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Treatment options for nonalcoholic steatohepatitis - a safety evaluation.
@en
type
label
Treatment options for nonalcoholic steatohepatitis - a safety evaluation.
@en
prefLabel
Treatment options for nonalcoholic steatohepatitis - a safety evaluation.
@en
P2093
P2860
P1476
Treatment options for nonalcoholic steatohepatitis - a safety evaluation.
@en
P2093
Arun J Sanyal
Danny Issa
Julia Wattacheril
P2860
P304
P356
10.1080/14740338.2017.1343299
P407
P577
2017-06-22T00:00:00Z